Source · Select Committees · Business and Trade Committee
Recommendation 17
17
If the Government cannot publish the Impact Assessment for the Pharmaceutical Arrangement, it should publish...
Recommendation
If the Government cannot publish the Impact Assessment for the Pharmaceutical Arrangement, it should publish its evidence that accelerating spend on innovative medicines will increase investment in the UK. (Recommendation, Paragraph 82) 61